Fiscal 2026 2nd Quarter Financial Results
Filed with TSE · · 54 pages · English
Asahi Kasei Corporation on 6ix
In the deck
Story so far
Earlier from Asahi Kasei
- Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production
- Asahi Kasei Strengthens Carbon Footprint Transparency for Acrylonitrile Production with Independent Third-Party Verification
- Announcement of cancellation of treasury stock
- Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults
- Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics
Follow Asahi Kasei into a list and get an email when it puts out news.
Follow Asahi Kasei